[
    [
        {
            "time": "",
            "original_text": "金域医学(603882.SH)股东君睿祺及一致行动人未减持股份 减持时间过半",
            "features": {
                "keywords": [
                    "金域医学",
                    "君睿祺",
                    "一致行动人",
                    "未减持",
                    "减持时间过半"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "金域医学(603882.SH)股东君睿祺及一致行动人未减持股份 减持时间过半",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "金域医学：君睿祺及君联茂林减持时间已过半，未减持公司股份",
            "features": {
                "keywords": [
                    "金域医学",
                    "君睿祺",
                    "君联茂林",
                    "减持时间过半",
                    "未减持"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "金域医学：君睿祺及君联茂林减持时间已过半，未减持公司股份",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "医药生物行业中报透视CXO：板块增长强劲 边际变化持续向好",
            "features": {
                "keywords": [
                    "医药生物",
                    "中报",
                    "CXO",
                    "板块增长强劲",
                    "边际变化向好"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业中报透视CXO：板块增长强劲 边际变化持续向好",
                "Correlation": 6,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]